VOR logo

Vor Biopharma (VOR) Cash From Operations

VOR Annual CFO

-$100.29 M
-$15.15 M-17.79%

31 December 2023

VOR Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VOR Quarterly CFO

-$23.29 M
-$1.44 M-6.58%

30 September 2024

VOR Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VOR TTM CFO

-$99.62 M
+$4.61 M+4.43%

30 September 2024

VOR TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VOR Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-17.8%+3.1%+0.7%
3 y3 years-176.3%+3.1%+0.7%
5 y5 years-3669.0%+3.1%+0.7%

VOR Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-45.0%at low-32.4%+23.6%-44.1%+6.5%
5 y5-year-917.7%at low-282.7%+23.6%-1537.2%+6.5%
alltimeall time-3669.0%at low-282.7%+23.6%-1537.2%+6.5%

Vor Biopharma Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
-$23.29 M(+6.6%)
-$99.62 M(-4.4%)
June 2024
-
-$21.85 M(-28.3%)
-$104.24 M(-2.1%)
Mar 2024
-
-$30.46 M(+26.8%)
-$106.49 M(+6.2%)
Dec 2023
-$100.29 M(+17.8%)
-$24.03 M(-13.9%)
-$100.29 M(+6.0%)
Sept 2023
-
-$27.90 M(+15.8%)
-$94.61 M(+10.5%)
June 2023
-
-$24.10 M(-0.7%)
-$85.62 M(-1.0%)
Mar 2023
-
-$24.27 M(+32.3%)
-$86.51 M(+1.6%)
Dec 2022
-$85.14 M
-$18.35 M(-2.9%)
-$85.14 M(+0.9%)
Sept 2022
-
-$18.90 M(-24.4%)
-$84.39 M(+1.9%)
June 2022
-
-$24.99 M(+9.1%)
-$82.83 M(+11.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$22.90 M(+30.2%)
-$74.40 M(+7.6%)
Dec 2021
-$69.14 M(+90.5%)
-$17.59 M(+1.4%)
-$69.14 M(+6.1%)
Sept 2021
-
-$17.34 M(+4.7%)
-$65.19 M(+16.2%)
June 2021
-
-$16.57 M(-6.1%)
-$56.09 M(+17.2%)
Mar 2021
-
-$17.65 M(+29.4%)
-$47.86 M(+31.9%)
Dec 2020
-$36.29 M(+268.3%)
-$13.63 M(+65.4%)
-$36.29 M(+60.2%)
Sept 2020
-
-$8.24 M(-1.0%)
-$22.66 M(+57.2%)
June 2020
-
-$8.33 M(+36.9%)
-$14.41 M(+136.9%)
Mar 2020
-
-$6.08 M
-$6.08 M
Dec 2019
-$9.86 M(+270.3%)
-
-
Dec 2018
-$2.66 M
-
-

FAQ

  • What is Vor Biopharma annual cash flow from operations?
  • What is the all time high annual CFO for Vor Biopharma?
  • What is Vor Biopharma annual CFO year-on-year change?
  • What is Vor Biopharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Vor Biopharma?
  • What is Vor Biopharma quarterly CFO year-on-year change?
  • What is Vor Biopharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Vor Biopharma?
  • What is Vor Biopharma TTM CFO year-on-year change?

What is Vor Biopharma annual cash flow from operations?

The current annual CFO of VOR is -$100.29 M

What is the all time high annual CFO for Vor Biopharma?

Vor Biopharma all-time high annual cash flow from operations is -$2.66 M

What is Vor Biopharma annual CFO year-on-year change?

Over the past year, VOR annual cash flow from operations has changed by -$15.15 M (-17.79%)

What is Vor Biopharma quarterly cash flow from operations?

The current quarterly CFO of VOR is -$23.29 M

What is the all time high quarterly CFO for Vor Biopharma?

Vor Biopharma all-time high quarterly cash flow from operations is -$6.08 M

What is Vor Biopharma quarterly CFO year-on-year change?

Over the past year, VOR quarterly cash flow from operations has changed by +$741.00 K (+3.08%)

What is Vor Biopharma TTM cash flow from operations?

The current TTM CFO of VOR is -$99.62 M

What is the all time high TTM CFO for Vor Biopharma?

Vor Biopharma all-time high TTM cash flow from operations is -$6.08 M

What is Vor Biopharma TTM CFO year-on-year change?

Over the past year, VOR TTM cash flow from operations has changed by +$669.00 K (+0.67%)